TRex Bio, Inc. (TRXB) Expects Cash Through H2 2029 After Approx. $119M IPO

TRex Bio reported Q3 2026 financial results; the supplied release includes no financial statement figures. Its October IPO generated approximately $119M in net proceeds, and the company expects resources to fund operations into H2 2029.Material DetailsContext by AI AnalystThis update comes from a c…